Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
复制标题
DOI:
10.1016/j.ijrobp.2018.06.048
复制
发表时间:
2018-11-15
期刊:
影响因子:
--
通讯作者:
El Naqa I
中科院分区:
文献类型:
--
作者:
Rosen BS;Hawkins PG;Polan DF;Balter JM;Brock KK;Kamp JD;Lockhart CM;Eisbruch A;Mierzwa ML;Ten Haken RK;El Naqa I
To determine whether serial cone-beam computed tomography (CBCT) images taken during head and neck radiotherapy (HNR) can improve chronic xerostomia prediction In a retrospective analysis, parotid glands (PGs) were delineated on daily kV CBCT images using deformable image registration (DIR) for 119 HNR patients (60 or 70 Gy in 2 Gy/fraction over 6 or 7 weeks). DIR accuracy for a subset of deformed contours was quantified using the Dice similarity coefficient (DSC) and mean distance-to-agreement (MDA) in comparison to manually drawn contours. Average weekly changes in CBCT-measured mean HU intensity and volume were calculated for each PG relative to week 1. Dose-volume-histogram (DVH) statistics were extracted from each plan, and interactions between dose, volume, and intensity were investigated. Univariable analysis and penalized logistic regression were used to analyze association with observer-rated xerostomia at one year following HNR. Models including CBCT delta imaging features were compared to clinical/DVH-only models using area under the receiver-operating characteristic curve (AUC) for Grade 1 or higher (Grade≥1) and for Grade 2 or higher (Grade≥2) xerostomia prediction. All patients experienced end-treatment PG volume reduction with mean (range) ipsilateral and contralateral PG shrinkage of 19.6% (0.9-58.4%) and 17.7% (4.4-56.3%), respectively. Mid-treatment volume change was highly correlated with mean PG dose (r=−0.318, p<1e-6). Incidence of Grade≥1 and Grade≥2 xerostomia was 65% and 16%, respectively. For Grade≥1 xerostomia prediction, the delta-imaging model had AUC = 0.719 (95% CI: 0.603-0.830), compared to 0.709 (95% CI: 0.603-0.815) for the dose/clinical model. For Grade≥2 xerostomia prediction, the dose/clinical model had AUC = 0.692 (95% CI: 0.615-0.770), and the addition of contralateral PG changes modestly improved predictive performance with AUC = 0.776 (0.643-0.912). The rate of CBCT-measured PG image feature changes improves prediction for chronic xerostomia prediction over dose alone. Analysis of CBCT images acquired for treatment positioning may provide an inexpensive monitoring system to support toxicity-reducing adaptive radiotherapy.
登录
查看更多内容
影响因子:
3.8
作者:
Jin, Jian-Yue;Ren, Lei;Chetty, Indrin J.
通讯作者:
Chetty, Indrin J.
影响因子:
3.8
作者:
Brock, Kristy K.;Mutic, Sasa;Kessler, Marc L.
通讯作者:
Kessler, Marc L.
影响因子:
5.7
作者:
Castadot, Pierre;Lee, John Aldo;Gregoire, Vincent
通讯作者:
Gregoire, Vincent
影响因子:
4.2
作者:
Jiang, Nan;Zhao, Yue;Martensson, Jan
通讯作者:
Martensson, Jan
影响因子:
5.7
作者:
Castadot, Pierre;Geets, Xavier;Gregoire, Vincent
通讯作者:
Gregoire, Vincent